Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
DGX
DGX
NYSE
Health Services
Services to the Health Industry
227.86
USD
-0.04
-0.02%
Kapalı: 07-24 20:00 (UTC+0)
227.86
USD
+0
+0.00%
Seans sonrası: 07-25 00:00 (UTC+0)

DGX Temel İstatistikler

YÜKSEK
233.21
Açık
228.00
Hacim
1.54M
Düşük
223.42
Önceki Kapanış
227.90
İşlem Değeri
353.86M
52H En Yüksek
237.78
Göreceli Hacim
1.414
Dalgalanma (%)
4.30%
52H En Düşük
165.78
Devir Oranı
1.39%
Piyasa Değeri
25.14B
F/K (TTM)
24.17
F/K (Yıllık)
25.689
GD/DD
3.35
F/S
2.18
Hisse Başına Kazanç (EPS)
9.427
Temettü (TTM)
3.737
Temettü Verimi
1.44%
Dolaşımdaki hisseler
110.69M
Para Birimi
USD

DGX Fiyat Performansı

7 gün
30 gün
90 gün
180 gün
Yıl başından bugüne
1 Yıl
DGX Para Akışı Dağılımı
DGX Günlük Açığa Satış Hacmi
DGX Short Interest Geçmişi
As of 2026-07-26, the Quest Diagnostics Incorporated (DGX) stock price today is 227.86. Based on this price, the company has a market capitalization of $25.14B, with a P/E ratio of 24.17. On 2026-07-26, DGX traded between 223.42 and 233.21. Today’s stock price is 1.99% above the daily low and 2.29% below the daily high, placing DGX orta seviyesine yakın its most recent trading range. Trading volume currently stands at 1.54M, compared with an average daily volume of 1.09M. This suggests that trading activity is olağan seviyesinin üzerinde than usual. Over the past year, Quest Diagnostics Incorporated shares have traded between 165.78 and 237.78. At today’s price, DGX is 37.45% above its 52-week low and 4.17% below its 52-week high.
Şirket adı
Quest Diagnostics Incorporated
Sektör
Health Services
Endüstri
Services to the Health Industry
Borsalar
NYSE
Çalışan Sayısı
57,000
Lot Büyüklüğü
100
Resmî web sitesi
Para Birimi
USD
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

DGX FAQ

Ara
Daha fazla